Fenofibrate promotes PPARα-targeted recovery of the intestinal epithelial barrier at the host-microbe interface in dogs with diabetes mellitus
Abstract Diabetes mellitus (DM) is associated with a dysfunctional intestinal barrier and an increased risk for systemic infection and inflammation in people, though the pathogenic mechanisms leading to this are poorly understood. Using a canine model of DM, we showed that the peroxisomal proliferat...
Guardado en:
Autores principales: | Katti R. Crakes, Jully Pires, Nina Quach, Riley E. Ellis-Reis, Rachel Greathouse, Kathyrnne A. Chittum, Jörg M. Steiner, Patricia Pesavento, Stanley L. Marks, Satya Dandekar, Chen Gilor |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/fc8522dc657f47b5bd02084f12d335f5 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
CLINICAL EFFICIENCY AND SAFETY OF FENOFIBRATE, A PPARα AGONIST, IN THE PATIENTS WITH DIABETESASSOCIATED OSTEOARTHRITIS: A CROSS-OVER PILOT STUDY
por: V. S. Shirinsky, et al.
Publicado: (2017) -
The PPARα Agonist Fenofibrate Prevents Formation of Protein Aggregates (Mallory-Denk bodies) in a Murine Model of Steatohepatitis-like Hepatotoxicity
por: Aniket Nikam, et al.
Publicado: (2018) -
Pleiotropic effects of fenofibrate: focus on type 2 diabetes mellitus
por: Alexander Sergeevich Ametov, et al.
Publicado: (2014) -
Scaffold-based pan-agonist design for the PPARα, PPARβ and PPARγ receptors.
por: Li-Song Zhang, et al.
Publicado: (2012) -
PLEIOTROPIC EFFECTS OF SIMVASTATIN AND FENOFIBRATE IN PATIENTS WITH RHEUMATOID ARTHRITIS: A COMPARATIVE STUDY
por: I. V. Shirinsky, et al.
Publicado: (2019)